Trials / Completed
CompletedNCT03594721
Clinical Trial Evaluation of a Test Serum Post HEV (High Energy Visible) Light Exposure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate 10 days of pretreatment with a serum (Test Product/Marvel AM) to the lower back, followed by a single exposure of 90J/cm2 HEV (High Energy Visible) light {400-450nm wavelengths} in healthy male or female volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Marvel AM | Study staff will perform each application of approximately 2 mg/cm2 or 50 µL of test product to the appropriate 5x5cm2 test location on the lower back at each of ten sequential visits. |
Timeline
- Start date
- 2018-08-06
- Primary completion
- 2018-08-30
- Completion
- 2018-08-30
- First posted
- 2018-07-20
- Last updated
- 2018-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03594721. Inclusion in this directory is not an endorsement.